Elevated Capital Advisors, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Elevated Capital Advisors, LLC

  • $322 Million
  • Q4 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Oct 07, 2021
SELL
$574.03 - $680.96 $1.12 Million - $1.33 Million
-1,956 Closed
0 $0
Q1 2021

Apr 21, 2021
BUY
$446.73 - $548.2 $111,235 - $136,501
249 Added 14.59%
1,956 $987,000
Q4 2020

Feb 25, 2021
BUY
$478.3 - $607.98 $118,618 - $150,779
248 Added 17.0%
1,707 $825,000
Q3 2020

Nov 27, 2020
SELL
$544.75 - $658.21 $110,584 - $133,616
-203 Reduced 12.21%
1,459 $816,000
Q2 2020

Sep 11, 2020
BUY
$493.32 - $643.92 $819,897 - $1.07 Million
1,662 New
1,662 $1.01 Million

Others Institutions Holding REGN

# of Institutions
1,503
Shares Held
82.7M
Call Options Held
1.22M
Put Options Held
1.51M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $74.5B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Elevated Capital Advisors, LLC Portfolio

Follow Elevated Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Elevated Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Elevated Capital Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email